The announcement comes a week after CureVac, a German biotech firm,
said its COVID-19 vaccine was only 47% effective in a late-stage
trial, missing the study's main goal and casting doubt on the
potential delivery of hundreds of millions of doses to the EU.
The additional Moderna doses will be delivered next year, the EU
executive said in a statement. The shots are part of a contract for
300 million doses, approved in February, of which half has already
been ordered by the 27-nation bloc.
![](http://archives.lincolndailynews.com/2021/Jun/22/images/ads/current/rohlfs_lda_072017.png)
[to top of second column] |
![](http://archives.lincolndailynews.com/2021/Jun/22/images/ads/current/2021_lda_Businessdirectory.png) The EU has also already ordered
another 160 million Moderna shots under an
initial supply contract signed in November.
The EU Commission said the second contract with
Moderna had also been amended to allow the
purchase of vaccines adapted to virus variants
as well as jabs for paediatric use and boosters.
(Reporting by Francesco Guarascio; Editing by
Alex Richardson and Louise Heavens)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |